The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocationIMAI, Yasuo; YOSHIMORI, Mayumi; FUKUDA, Kazunori et al.Oncology reports. 2012, Vol 27, Num 6, pp 1703-1709, issn 1021-335X, 7 p.Article

Clinical features of adult-onset chronic active Epstein―Barr virus infection: a retrospective analysisARAI, Ayako; IMADOME, Ken-Ichi; WATANABE, Yuko et al.International journal of hematology. 2011, Vol 93, Num 5, pp 602-609, issn 0925-5710, 8 p.Article